tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Technical Analysis

Compare
328 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Keros Therapeutics is a Sell.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 11.37, while Keros Therapeutics’s (KROS) share price is $11.29, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 14.57, while Keros Therapeutics’s (KROS) share price is $11.29, making it a Sell.

Keros Therapeutics (KROS) Pivot Points

Mar 28, 2025, 05:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.78
10.95
11.12
11.29
11.46
11.63
11.80
Fibonacci
10.95
11.08
11.16
11.29
11.42
11.50
11.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Mar 28, 2025, 05:04 AM
Period
Simple
Exponential
MA5
11.28Sell
11.24Sell
MA10
11.38Sell
11.32Sell
MA20
11.39Sell
11.37Sell
MA50
11.18Sell
14.57Sell
MA100
27.29Sell
23.33Sell
MA200
39.27Sell
35.13Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 11.32, while Keros Therapeutics’s (KROS) share price is $11.29, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 23.33, while Keros Therapeutics’s (KROS) share price is $11.29, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $11.29 and Keros Therapeutics’s (KROS) 50-day simple moving average is 11.18, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $11.29 and Keros Therapeutics’s (KROS) 100-day simple moving average is 27.29, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $11.29 and Keros Therapeutics’s (KROS) 200-day simple moving average is 39.27, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Mar 28, 2025, 05:04 AM
Name
Value
Implied Action
RSI (14)
40.43
Neutral
STOCH (9,6)
24.41
Neutral
STOCHRSI (14)
39.11
Neutral
MACD (12,26)
-0.26
Sell
ADX (14)
14.75
Buy
Williams %R
-72.44
Buy
CCI (14)
-107.32
Buy
ATR (14)
0.54
-
Ultimate Oscillator
44.50
Neutral
ROC
-7.71
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 40.43, creating a Neutral signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 14.75, creating a Buy signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -107.32, creating a Buy signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -7.71, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Strong Sell.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 40.43, which suggests KROS is a Neutral.
      What is KROS’s MACD?
      KROS’s MACD is -0.26, which suggests KROS is a Sell.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 11.28, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 11.39, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 11.18, which suggests KROS is a Sell.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 39.27, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -72.44, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -107.32, which suggests KROS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis